23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.19%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-5.19%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-22.91%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-22.91%
Negative operating income growth while Insurance - Life median is -0.07%. Seth Klarman would check if structural or cyclical issues are at play.
-33.04%
Negative net income growth while Insurance - Life median is -4.91%. Seth Klarman would investigate factors dragging net income down.
-33.05%
Negative EPS growth while Insurance - Life median is -1.29%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-33.05%
Negative diluted EPS growth while Insurance - Life median is -1.29%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.94%
OCF growth exceeding 1.5x Insurance - Life median of 14.37%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.
57.94%
FCF growth exceeding 1.5x Insurance - Life median of 14.09%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
153.59%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 32.37%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
87.89%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 31.61%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
3230.96%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 14.92%. Joel Greenblatt might see a short-term competitive advantage at play.
112.51%
OCF/share CAGR of 112.51% while Insurance - Life median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
58.06%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 5.08%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
30.02%
3Y OCF/share growth > 1.5x Insurance - Life median of 11.92%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
-27.20%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 1.99%. Seth Klarman might see a fundamental problem if peers maintain growth.
40.33%
5Y net income/share CAGR > 1.5x Insurance - Life median of 20.77%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
130.43%
3Y net income/share CAGR > 1.5x Insurance - Life median of 12.66%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
76.48%
Equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might credit disciplined reinvestment or conservative payout ratios for outperformance.
68.11%
5Y equity/share CAGR > 1.5x Insurance - Life median of 39.32%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
58.86%
3Y equity/share CAGR > 1.5x Insurance - Life median of 31.67%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.66%
AR shrinking while Insurance - Life median grows. Seth Klarman sees potential advantage unless it signals declining demand.
No Data
No Data available this quarter, please select a different quarter.
4.14%
Asset growth exceeding 1.5x Insurance - Life median of 2.74%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
2.50%
Near Insurance - Life median. Charlie Munger considers it standard net worth compounding for the sector.
15.21%
Debt growth of 15.21% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
3.24%
SG&A growth of 3.24% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.